Latest pulmonary atresia Stories
ATLANTA, July 7, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today a $3.5 million equity investment in ValveXchangeÂ® Inc.
St. Joseph's Children's Hospital is among a small number of facilities in the country to offer the less-invasive procedure for valve replacement. TAMPA, Fla., June 9, 2011 /PRNewswire-USNewswire/ -- When cardiologists at St.
ATLANTA, Oct. 12 /PRNewswire/ -- More than 100 cardiovascular surgeons and cardiologists from 25 countries are scheduled to attend the third annual global Ross Summit, a two-day surgical congress focused on the Ross Procedure.
ATLANTA, June 8 /PRNewswire-FirstCall/ -- CryoLife, Inc., (NYSE: CRY) a biomaterials, medical device and tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoValveÂ® SG pulmonary human heart valve processed with the Company's proprietary SynerGraftÂ® technology.
ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- CryoLife, Inc.
Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension.
ATLANTA, Aug. 12 /PRNewswire-FirstCall/ -- CryoLife, Inc., (NYSE: CRY) an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the U.S.
ST. LOUIS, July 16 /PRNewswire-FirstCall/ -- Stereotaxis, Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.